Trump Didn't 'Cancel Cancer Research' — But His Directives Paused NIH Meetings To Dole Out Funds
Meetings designed to distribute grant money to fund research were canceled as part of a communications freeze at health ...
EurekAlert!4d
‘Pushing the boundaries of radiation treatment’: Breakthrough in pancreatic cancer therapy advances to clinical trials
A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for ...
MD Anderson Cancer Center will break ground on $239M research building near Helix Park
The University of Texas MD Anderson Cancer Center plans to further expand ... The facility will support pre-clinical research ...
Yahoo Finance27d
MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assay
HOUSTON and SALT LAKE CITY, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The University of Texas MD Anderson Cancer Center and ... Genetics and the clinical and translational research expertise of MD ...
EurekAlert!5d
In HER2+ colorectal cancer, anti-HER2 therapy may be less toxic alternative
A phase 2 trial finds that for patients with HER2+ metastatic colorectal cancer, dual HER2-inhibitor therapy can be a similarly efficacious but less toxic alternative to EGFR inhibitor therapy.
Hosted on MSN9mon
Rush, MD Anderson Cancer Center announce new partnership
MD Anderson is known for having the world's largest cancer clinical ... of physicians and research experts coming from MD Anderson. In addition to Rush University Medical Center in Chicago ...
appliedclinicaltrialsonline5d
Pfizer Shares Positive Data from Phase III BREAKWATER Trial of Braftovi Combination Following Accelerated Approval
Being evaluated for the treatment of metastatic colorectal cancer, the combination regimen achieved an objective response ...
Forbes1y
MD Anderson Cancer Center
Forbes does not accept payment for placement on lists. This company paid for expanded information and features to appear on their Forbes Profile. For more information, click here. From MD Anderson ...